Table 1.
The expression of CTA in the digestive tract cancers.
| Cancer type | Name | Positive/total | Reference |
|---|---|---|---|
| Esophagus cancer | MAGE-1 | 26/42 | 21 |
| MAGE-2 | 18/42 | 21 | |
| MAGE-3 | 24/42 | 21 | |
| MAGE-A family | 38/98 | 22 | |
| MAGE-A family | 111/213 | 23 | |
| MAGE-A4 | 38/41 | 25 | |
| MAGE-A9 | 57/103 | 26 | |
| MAGE-A3 | 11/12 | 27 | |
| MAGE-A11 | 37/96 | 28 | |
| BAGE | Low/48 | 29 | |
| GAGE | Low/48 | 29 | |
| GAGE | 42/213 | 23 | |
| NY-ESO | 41/123 | 31 | |
| NY-ESO | 44/213 | 23 | |
| NY-ESO | 17/41 | 25 | |
| BORIS | 28/50 | 33 | |
| LAGE1 | 16/41 | 25 | |
| Gastric cancer | MAGE-C2 | 5/51 | 36 |
| MAGE-A1 | 47/86 | 37 | |
| MAGE-A1 | 4/41 | 38 | |
| GAGE | 6/51 | 36 | |
| MAEL | 17/80 | 39 | |
| TSP50 | 191/334 | 41 | |
| CT55 | 3/14 | 51 | |
| Colorectal cancer | MAGE-A family | None/34 | 42 |
| MAGE-A2 | 87/100 | 45 | |
| MAGE-A7 | 83/100 | 45 | |
| MAGE-A8 | 75/100 | 45 | |
| MAGE-A12 | 71/100 | 45 | |
| MAGE-B2 | 75/100 | 45 | |
| MAGE-B3 | 79/100 | 45 | |
| MAGE-D2 | 75/100 | 45 | |
| MAGE-F1 | 79/100 | 45 | |
| MAGE -H1 | 70/100 | 45 | |
| MAGE-1 | 14/121 | 44 | |
| MAGE-3 | 33/121 | 44 | |
| MAGE-4 | 27/121 | 44 | |
| CAGE | 31/34 | 42 | |
| LAGE-1 | 19/121 | 44 | |
| NY-ESO-1 | 2/34 | 42 | |
| NY-ESO-1 | 12/121 | 44 | |
| NY-ESO-1 | None/62 | 5 | |
| SSX-1 | 6/121 | 44 | |
| SSX-2 | 3/121 | 44 | |
| SSX-2 | 2/34 | 42 | |
| SSX-4 | 3/121 | 44 | |
| SSX-4 | 3/34 | 42 | |
| CT-10 | 8/121 | 44 | |
| SCP-1 | 2/121 | 44 | |
| SPAG9 | 41/62 | 5 | |
| AKAP4 | 27/62 | 5 | |
| Biot2 | 108/147 | 46 | |
| BCP-20 | 22/57 | 47 | |
| HSPA2 | 156/200 | 48 | |
| LEMD1 | 17/18 | 49 | |
| IGF2BP3 | 56/110 | 50 | |
| SPAG1 | 15/110 | 50 | |
| ATAD | 92/110 | 50 | |
| CTA55 | 3/18 | 51 | |
| PLAP | 25/116 | 52 |